• Home
  • About Us
    • Who we are
    • Our Early History
    • Technology
    • Target Markets
      • Venous and pressure ulcers
      • Other Applications
    • Business Model
    • Licensing
    • Clinical Trial
    • Publications & Presentations
    • Company Milestones
    • Focus
  • The Company
    • Board & Management
      • Paul Wright
      • Mark Richardson
      • George Baumanis
  • Advisory Team
    • Intellectual Property
      • Vaughan Barlow
      • Tom Boyce
      • Audrey Yap
      • Yvette Flanigan
    • Principal Advisor
      • Mark Woolley
    • Medical and Scientific Advisory Committee
      • James Fries
      • Michael Woodward
    • Scientific
      • Richard Lipscombe
    • Clinical
      • Geoffrey Mitchell
    • Health Economics
      • Nicholas Graves
  • Media
  • Links
  • Members Log in
  • Contact Us

News Headlines

> 18/01/10
Phoenix Eagle commences clinical trial.


> 01/12/09
OPAL A-1001 clinical trial has been approved by the Human Research Ethics Committee of the Austin Hospital.

Welcome to Phoenix Eagle

Phoenix Eagle’s purpose is to develop, protect and commercialise IP arising from the application of the Company’s patented OPAL process to fruits and vegetables to create products that enhance health and quality of life globally.

Our core asset is our proprietary IP. Patent applications have been filed in the important global markets. To date, patents have been granted in six jurisdictions.

We have developed a range of topically applied products which we call OPAL Products. These products are created from fruits and vegetables that have been subjected to the OPAL Process, which results in the formation of complex products with remarkable therapeutic and cosmetic properties.

The OPAL process is a platform technology that may lead to products across multiple global markets. Our target markets are large and have significant unmet needs.

Developing products that enhance health and quality of life globally

The Phoenix Eagle Company Pty Ltd website is proudly maintained by NetBiz Enterprises.